| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |